These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31668745)

  • 21. Severe aortic insufficiency secondary to 5L Impella device placement.
    Chandola R; Cusimano R; Osten M; Horlick E
    J Card Surg; 2012 May; 27(3):400-2. PubMed ID: 22621723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valvular complications following the Impella device implantation.
    Sef D; Kabir T; Lees NJ; Stock U
    J Card Surg; 2021 Mar; 36(3):1062-1066. PubMed ID: 33410194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aortic valve insufficiency after Impella device insertion that required aortic valve replacement after Heart Mate III left ventricular assist device implantation: a case report.
    Ueda K; Yoshitani K; Hosotani S; Hayashi H; Fukushima S; Ohnishi Y
    J Surg Case Rep; 2021 Oct; 2021(10):rjab420. PubMed ID: 34667589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient size parameters to guide use of the Impella device in pediatric patients.
    Morray BH; Dimas VV; McElhinney DB; Puri K; Qureshi AM
    Catheter Cardiovasc Interv; 2019 Oct; 94(4):618-624. PubMed ID: 31424167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience.
    Siegenthaler MP; Brehm K; Strecker T; Hanke T; Nötzold A; Olschewski M; Weyand M; Sievers H; Beyersdorf F
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):812-22. PubMed ID: 15001911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical transaxillary placement of the Impella 5.0 ventricular assist device.
    Bertoglio L; Katsarou M; Scandroglio M; Bertoldi L; Chiesa R; Pappalardo F
    J Card Surg; 2019 Feb; 34(2):92-98. PubMed ID: 30625252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse Events and Modes of Failure Related to Impella RP: Insights from the Manufacturer and User Facility Device Experience (MAUDE) Database.
    Khalid N; Rogers T; Shlofmitz E; Chen Y; Musallam A; Khan JM; Iantorno M; Gajanana D; Hashim H; Torguson R; Bernardo N; Waksman R
    Cardiovasc Revasc Med; 2019 Jun; 20(6):503-506. PubMed ID: 30922871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.
    Tanaka Y; Nakajima T; Fischer I; Wan F; Kotkar K; Moon MR; Damiano RJ; Masood MF; Itoh A
    J Thorac Cardiovasc Surg; 2020 Dec; 160(6):1490-1500.e3. PubMed ID: 32998831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. It keeps on turning: Effects of prolonged long-term left ventricular assist device support as a bridge to heart transplantation.
    Schmack B; Grossekettler L; Zeriouh M; Weymann A; Mohite P; Koch A; Ruhparwar A; Simon AR; Sabashnikov A; Popov AF
    Int J Artif Organs; 2019 Feb; 42(2):65-71. PubMed ID: 30580668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Impella 5.0 Prior to Transcatheter Aortic Valve Replacement in a Patient with Severe Aortic Stenosis and Cardiogenic Shock.
    Johnson DW; ErwinIII JP
    J Heart Valve Dis; 2017 Jul; 26(4):485-487. PubMed ID: 29302950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency.
    Retzer EM; Sayer GT; Fedson SE; Nathan S; Jeevanandam V; Friant J; Uriel N; Lang RM; Russo MJ; Shah AP
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):971-9. PubMed ID: 26527571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patients.
    Dimas VV; Morray BH; Kim DW; Almond CS; Shahanavaz S; Tume SC; Peng LF; McElhinney DB; Justino H
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):124-129. PubMed ID: 28295963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insertion of an Abiomed Impella® left ventricular assist device following bioprosthetic aortic valve placement.
    Thomas MP; Altman A; Magovern GJ; Moraca RJ
    J Card Surg; 2013 Jul; 28(4):469-71. PubMed ID: 23675749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes.
    Cheung AW; White CW; Davis MK; Freed DH
    J Heart Lung Transplant; 2014 Aug; 33(8):794-9. PubMed ID: 24726682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices.
    Schechter MA; Joseph JT; Krishnamoorthy A; Finet JE; Ganapathi AM; Lodge AJ; Milano CA; Patel CB
    J Heart Lung Transplant; 2014 Sep; 33(9):937-42. PubMed ID: 24997496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.